Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42b66fd6ac8d432f925152eef843ebe7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 |
filingDate |
2003-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_269fc9b31e4f6dfdd3b14d939c704466 |
publicationDate |
2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-536017-A |
titleOfInvention |
Compositions containing an anti-neoplastic agent and a growth hormone recepter antagonist for treating a neoplasm |
abstract |
Disclosed is a composition comprising an anti-neoplastic agent and a growth hormone receptor antagonist, wherein said anti-neoplastic agent comprises a campothecin. Compositions of the type disclosed are useful for the delaying or preventing of clinical onset of a neoplasm, in particular a malignant neoplasm. |
priorityDate |
2002-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |